Nataniel H. Lester-Coll, Samuel Z. Goldhaber, David J. Sher and Anthony V. D'Amico Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy Cancer 119
Version of Record online: 7 FEB 2013 | DOI: 10.1002/cncr.27980
Men with a history of myocardial infarction who receive radiation therapy experience net harm when they receive hormonal therapy. Men without a history of myocardial infarction gain a quality-adjusted life-expectancy benefit from hormonal therapy; therefore, the optimal duration of hormonal therapy is a function of patient age and the number of cardiac risk factors.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field